Synovus Financial’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,694
Closed -$417K 804
2020
Q4
$417K Buy
2,694
+119
+5% +$15.3K ﹤0.01% 583
2020
Q3
$292K Sell
2,575
-130
-5% -$14K ﹤0.01% 607
2020
Q2
$304K Sell
2,705
-3,364
-55% -$357K ﹤0.01% 577
2020
Q1
$559K Buy
6,069
+3,585
+144% +$352K 0.01% 494
2019
Q4
$267K Buy
2,484
+93
+4% +$9.95K ﹤0.01% 617
2019
Q3
$230K Buy
2,391
+106
+5% +$11.9K ﹤0.01% 630
2019
Q2
$302K Buy
2,285
+83
+4% +$10.7K ﹤0.01% 539
2019
Q1
$298K Buy
2,202
+1,678
+320% +$209K ﹤0.01% 521
2018
Q4
$52K Buy
524
+65
+14% +$7.68K ﹤0.01% 786
2018
Q3
$63K Buy
459
+353
+333% +$44.3K ﹤0.01% 783
2018
Q2
$13K Hold
106
﹤0.01% 1025
2018
Q1
$12K Sell
106
-2,002
-95% -$239K ﹤0.01% 1017
2017
Q4
$252K Buy
2,108
+61
+3% +$7.43K ﹤0.01% 529
2017
Q3
$290K Sell
2,047
-13,190
-87% -$1.79M 0.01% 484
2017
Q2
$1.85M Sell
15,237
-549
-3% -$63.9K 0.04% 198
2017
Q1
$1.91M Buy
15,786
+701
+5% +$90.4K 0.04% 180
2016
Q4
$1.85M Sell
15,085
-1,024
-6% -$125K 0.04% 177
2016
Q3
$1.98M Buy
16,109
+442
+3% +$56.9K 0.05% 166
2016
Q2
$1.83M Buy
15,667
+4,421
+39% +$627K 0.04% 177
2016
Q1
$1.57M Buy
11,246
+10,420
+1,262% +$1.53M 0.04% 193
2015
Q4
$157K Buy
826
+815
+7,409% +$142K ﹤0.01% 483
2015
Q3
$2K Sell
11
-38
-78% -$6.93K ﹤0.01% 929
2015
Q2
$9K Sell
49
-94
-66% -$16.2K ﹤0.01% 856
2015
Q1
$24K Hold
143
﹤0.01% 742
2014
Q4
$26K Hold
143
﹤0.01% 729
2014
Q3
$24K Hold
143
﹤0.01% 716
2014
Q2
$23K Hold
143
﹤0.01% 689
2014
Q1
$21K Buy
+143
New +$22.7K ﹤0.01% 701

Other funds holding ALXN